New Vaccine Rids Cancerous Traces in Mice, Stanford University Research

New vaccine rids cancerous traces in mice according to the research from the Stanford University School of Medicine.

New research has discovered that instilling even a very few amount of two immune stimulating components directly into the solid tumors of mice can rid of all signs of cancers in them including untreated and distant metastatic growth. The study is expected to be working in several types of cancers along with those arriving spontaneously.


Oncology professor Ronald Levy, MD and scientist from the Stanford University said in a statement that, “When we use these two agents together, we see the elimination of tumors all over the body. This approach bypasses the need to identify tumor-specific immune targets and doesn’t require wholesale activation of the immune system or customization of a patient’s immune cells.”

Moreover, the researchers have notified that one of the components used in this cancer vaccinating approach has been approved to be used in human cases as well, while the other one is being tested for different unrelated clinical trials for human use. The clinical trial was attempted for testing the impacts of the treatment in lymphoma patients in January.

Dr. Levy is a leading author of the study published in the Science Translational Medicine on January 31. The research is a part of the focus of the university’s target on precision health, which aims to prevent and anticipate disease in the people with precisely diagnosing and eliminating it throughout.